HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Federico Hinestrosa Selected Research
Federico Hinestrosa Research Topics
Disease
9
Infections
05/2024 - 01/2014
4
Fibrosis (Cirrhosis)
01/2020 - 08/2015
2
Chronic Hepatitis C
12/2021 - 01/2014
1
Headache (Headaches)
05/2024
1
Liver Diseases (Liver Disease)
12/2021
1
Hepatitis
12/2021
1
Drug-Related Side Effects and Adverse Reactions
11/2020
1
Hepatitis C
12/2019
Drug/Important Bio-Agent (IBA)
6
Ribavirin (Virazole)
FDA Link
Generic
12/2019 - 01/2014
6
Sofosbuvir
IBA
12/2019 - 01/2014
3
velpatasvir
IBA
10/2017 - 12/2015
3
Protease Inhibitors (Protease Inhibitor)
IBA
11/2016 - 01/2014
3
daclatasvir
IBA
02/2016 - 01/2014
2
Antiviral Agents (Antivirals)
IBA
12/2021 - 10/2017
2
RNA (Ribonucleic Acid)
IBA
11/2020 - 01/2020
1
doravirine
IBA
05/2024
1
islatravir
IBA
05/2024
1
sofosbuvir drug combination ledipasvir
IBA
12/2021
1
glecaprevir and pibrentasvir
IBA
12/2019
1
L 644711 (B-3(+))
IBA
12/2019
1
Nucleotides
IBA
11/2016
1
voxilaprevir
IBA
11/2016
1
8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamide
IBA
02/2016
1
asunaprevir
IBA
02/2016
1
Interferons
IBA
02/2016
1
N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamide
IBA
01/2014
1
telaprevir
IBA
01/2014
Therapy/Procedure
4
Therapeutics
12/2019 - 01/2014
1
Aftercare (After-Treatment)
12/2019
1
Retreatment
10/2017